Search Results for "Adenosine Based Companies"
Original Source: Adenosine Therapeutics,LLC
Adenosine Therapeutics (AT), located in Charlottesville, VA, is a drug discovery and development company that was co-founded in 1999 by University of Virginia (UVa) Professor, Joel Linden and entrepreneur, Robert Capon (one of three cofounders of Virologic, NASDAQ: VLGC.) Although relatively young as a company, AT represents the fruition of over 40 years of academic research at UVa on the pharmacology and physiology of the endogenous neucleoside, adenosine. UVa's establishment as the academic leader in aden...
Matching Channels
Connecticut, a state in the north-east corner of the US is a hub for biotechnology companies. There are over 100 high-quality companies with global markets based in Connecticut. In 2004, Connectic...
Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renown...
In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over...
Germany is one the top 5 countries in Europe for the biotechnology industry. The €2 billion Innovative Medicines stimulus from the EU has helped, but that is spread over the continent. Over a d...
Matching News
Figure 1: Effects of adenosine A2A receptor agonism
Cover Story: Dissociating the effects of A2A agonism Figure 1. Effects of adenosine A2A receptor agonism. Activation of the adenosine A2A receptor (ADORA2A) is known to both inhibit inflammatory proce...
CHARLOTTESVILLE, Va. , April 1, 2013 /- Adenosine Therapeutics, LLC, a drug discovery and development company founded in 1999, announced today that it has engaged Needham & Company to explor...
This molecular probe may serve as a companion tool to identify and stratify patient populations based on the prevalence of the target A3 adenosine receptors. Small molecule drugs, A3AR-selective agon...
The Adenosine A2B Receptor and Diabetic Glomerulopathy
This animal study explores the pathogenic role of the adenosine A2B receptor in mediating early stages of renal dysfunction in diabetic nephropathy. Could this be a target for intervention? Laborato...
Beta testing adenosine receptor agonists
UCSF researchers have used a zebrafish screen to identify an adenosine receptor agonist that improved both beta cell regeneration and glucose control in diabetic mice. The discovery could open up a ne...
Sleep: Adenosine-based antidepressants?
Small Molecule MRS5474 with Anticonvulsant Activity for Treatment of Epilepsy
Adenosine modulates many physiological processes by activating specific adenosine receptors. These adenosine receptors play a critical role in the regulation of cellular signaling and are broadly dist...
Adenosine Therapeutics to explore strategic options for Stedivaze
Adenosine Therapeutics, LLC, a drug discovery and development company founded in 1999, announced today that it has engaged Needham & Company to explore strategic options for Stedivaze, a highly select...
Matching PubMed Articles
Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.
An emerging theory of schizophrenia postulates that hypofunction of adenosine signaling may contribute to its pathophysiology. This study was designed to test the "adenosine hypothesis" of schizophren...
Adenosine receptors as drug targets - what are the challenges?
Adenosine signalling has long been a target for drug development, with adenosine itself or its derivatives being used clinically since the 1940s. In addition, methylxanthines such as caffeine have pro...
StatBite Top 10 Pharmaceutical Companies.
A simple and reliable fluorescent molecular beacon is developed utilizing DNA-templated silver nanoclusters as a signal indicator and adenosine triphosphate (ATP) and adenosine deaminase as mechanical...
Adenosine A(1) receptors are inhibitory G-protein coupled receptors that presynaptically regulate neurotransmitter release, but their role in self-regulating adenosine release is not known. In this st...
